<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37671223</PMID><DateRevised><Year>2023</Year><Month>09</Month><Day>07</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Anxiety and Depression in COVID Survivors - A Cross-Sectional Study Six Months Past the Acute Illness.</ArticleTitle><Pagination><StartPage>e42971</StartPage><MedlinePgn>e42971</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e42971</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.42971</ELocationID><Abstract><AbstractText>Background Studies exploring the long-term psychiatric sequelae of COVID-19 are sparse. We aimed to assess depression and anxiety six months after recovery and the association between disease severity and psychiatric sequelae. Material and methods Our study was a comparative study conducted on COVID-19 disease survivors at a tertiary hospital. We compared Hamilton Depression Rating Scale (HDRS) scores and Hamilton Anxiety Rating Scale (HAM-A) scores between mild (n=50), moderate (n=50), severe cases (n=50), and controls (n=50). We assessed the severity of depression and anxiety using the HDRS and the HAM-A. Cases: First-time COVID-19 survivors six months post-recovery. Cases were healthy pre-COVID. To the study date, controls were negative for COVID-19 reverse transcription polymerase chain reaction (RT-PCR). Results Our study of 200 subjects indicated that mean&#xa0;(mean, SD) HAM-A scores in cases (14.7, 5.6) were higher than controls (7.9, 1.7), and&#xa0;HDRS scores in cases (17.3, 6.3) were higher than controls (7.5, 1.9). HAM-A scores in severe cases&#xa0;(19.5, 4.8)&#xa0;were higher than in moderate cases&#xa0;(17.0, 3.9), and scores in moderate cases were higher than in mild cases&#xa0;(10.6, 2.4). HDRS scores in severe cases (22.5, 5.9) were higher than in moderate cases (16.4, 3.2), and scores in moderate cases were higher than in mild cases (14.4, 2.5).&#xa0;Among the cases, there was a positive correlation between the Hamilton Anxiety Rating Scale (HAM-A) and Hamilton Depression Rating Scale (HDRS) scores and the duration of hospital stay, ICU stay, and use of invasive oxygen. These parameters were not applicable to the controls; hence, they were not included in the comparative analysis. Conclusions Patients, even after six months of recovery from COVID-19, had symptoms of anxiety and depression. The severity of anxiety and depression in survivors correlates with the severity of the COVID-19 disease.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023, Avula et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Avula</LastName><ForeName>Vijaya Chandra R</ForeName><Initials>VCR</Initials><AffiliationInfo><Affiliation>Psychiatry, All India Institute of Medical Sciences, Mangalagiri, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amalakanti</LastName><ForeName>Sridhar</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>General Medicine, All India Institute of Medical Sciences, Mangalagiri, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M</LastName><ForeName>Shashidhara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Psychiatry, All India Institute of Medical Sciences, Mangalagiri, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fasiha</LastName><ForeName>Afreen</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Pulmonology, All India Institute of Medical Sciences, Mangalagiri, IND.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">covid-19</Keyword><Keyword MajorTopicYN="N">long covid</Keyword><Keyword MajorTopicYN="N">long haul covid-19</Keyword><Keyword MajorTopicYN="N">post covid anxiety</Keyword><Keyword MajorTopicYN="N">post covid depression</Keyword><Keyword MajorTopicYN="N">post-acute covid-19 syndromes</Keyword><Keyword MajorTopicYN="N">post-covid condition</Keyword></KeywordList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>6</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>6</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>6</Day><Hour>3</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37671223</ArticleId><ArticleId IdType="pmc">PMC10475854</ArticleId><ArticleId IdType="doi">10.7759/cureus.42971</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>First confirmed case of COVID-19 infection in India: a case report. Andrews MA, Areekal B, Rajesh KR, et al. Indian J Med Res. 2020;151:490&#x2013;492.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7530459</ArticleId><ArticleId IdType="pubmed">32611918</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Data Explorer. Our World in Data. 2023. https://ourworldindata.org/explorers/coronavirus-data-explorer https://ourworldindata.org/explorers/coronavirus-data-explorer</Citation></Reference><Reference><Citation>In patients of COVID-19, what are the symptoms and clinical features of mild and moderate cases.  [
Mar;
2023 
]. 2021. https://www.cebm.net/covid-19/in-patients-of-covid-19-what-are-the-symptoms-and-clinical-features-of-mild-and-moderate-case/ https://www.cebm.net/covid-19/in-patients-of-covid-19-what-are-the-symptoms-and-clinical-features-of-mild-and-moderate-case/</Citation></Reference><Reference><Citation>How COVID-19 affects the brain. Boldrini M, Canoll PD, Klein RS. JAMA Psychiatry. 2021;78:682&#x2013;683.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9894299</ArticleId><ArticleId IdType="pubmed">33769431</ArticleId></ArticleIdList></Reference><Reference><Citation>Association of sociodemographic parameters with depression, anxiety, stress, sleep quality, psychological trauma, mental well-being, and resilience during the second wave of COVID-19 pandemic: a cross-sectional survey from India. Kaur T, Ranjan P, Chakrawarty A, et al. Cureus. 2021;13:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8364738</ArticleId><ArticleId IdType="pubmed">34414046</ArticleId></ArticleIdList></Reference><Reference><Citation>Public mental health problems during COVID-19 pandemic: a large-scale meta-analysis of the evidence. Liu X, Zhu M, Zhang R, et al. Transl Psychiatry. 2021;11:384.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8266633</ArticleId><ArticleId IdType="pubmed">34244469</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Rogers JP, Chesney E, Oliver D, et al. Lancet Psychiatry. 2020;7:611&#x2013;627.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7234781</ArticleId><ArticleId IdType="pubmed">32437679</ArticleId></ArticleIdList></Reference><Reference><Citation>Long-term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission: a systematic review and meta-analysis. Ahmed H, Patel K, Greenwood DC, et al. J Rehabil Med. 2020;52:0.</Citation><ArticleIdList><ArticleId IdType="pubmed">32449782</ArticleId></ArticleIdList></Reference><Reference><Citation>Long-term effects of coronavirus (long COVID)  [
Nov;
2022 
]. 2021. https://www.nhs.uk/conditions/coronavirus-covid-19/long-term-effects-of-coronavirus-long-covid/ https://www.nhs.uk/conditions/coronavirus-covid-19/long-term-effects-of-coronavirus-long-covid/</Citation></Reference><Reference><Citation>Coronavirus disease 2019 (COVID-19): cytokine storms, hyper-inflammatory phenotypes, and acute respiratory distress syndrome. Lin SH, Zhao YS, Zhou DX, Zhou FC, Xu F. Genes Dis. 2020;7:520&#x2013;527.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7323676</ArticleId><ArticleId IdType="pubmed">32837983</ArticleId></ArticleIdList></Reference><Reference><Citation>Identifying HAM-A cutoffs for mild, moderate, and severe generalized anxiety disorder. Matza LS, Morlock R, Sexton C, Malley K, Feltner D. Int J Methods Psychiatr Res. 2010;19:223&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6878292</ArticleId><ArticleId IdType="pubmed">20718076</ArticleId></ArticleIdList></Reference><Reference><Citation>Severity classification on the Hamilton Depression Rating Scale. Zimmerman M, Martinez JH, Young D, Chelminski I, Dalrymple K. J Affect Disord. 2013;150:384&#x2013;388.</Citation><ArticleIdList><ArticleId IdType="pubmed">23759278</ArticleId></ArticleIdList></Reference><Reference><Citation>Effect of the COVID-19 pandemic on the anxiety and depression levels in patients who applied to the cosmetology unit. Temiz SA, Durmaz K, Dursun R, et al. Dermatol Ther. 2021;34:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7744836</ArticleId><ArticleId IdType="pubmed">33274539</ArticleId></ArticleIdList></Reference><Reference><Citation>Risk factors associated with mental illness in hospital discharged patients infected with COVID-19 in Wuhan, China. Liu D, Baumeister RF, Veilleux JC, Chen C, Liu W, Yue Y, Zhang S. Psychiatry Res. 2020;292:113297.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7355324</ArticleId><ArticleId IdType="pubmed">32707218</ArticleId></ArticleIdList></Reference><Reference><Citation>Post-intensive care syndrome: an overview. Rawal G, Yadav S, Kumar R. J Transl Int Med. 2017;5:90&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5506407</ArticleId><ArticleId IdType="pubmed">28721340</ArticleId></ArticleIdList></Reference><Reference><Citation>Female sex is a risk factor associated with long-term post-Covid related-symptoms but not with COVID-19 symptoms: the long-COVID-EXP-cm multicenter study. Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Mart&#xed;n-Guerrero JD, Pellicer-Valero &#xd3;J, et al. J Clin Med. 2022;11:413.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8778106</ArticleId><ArticleId IdType="pubmed">35054108</ArticleId></ArticleIdList></Reference><Reference><Citation>Long Covid in adults discharged from UK hospitals after Covid-19: a prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol. Sigfrid L, Drake TM, Pauley E, et al. Lancet Reg Health Eur. 2021;8:100186.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8343377</ArticleId><ArticleId IdType="pubmed">34386785</ArticleId></ArticleIdList></Reference><Reference><Citation>Symptoms and health outcomes among survivors of COVID-19 infection 1 year after discharge from hospitals in Wuhan, China. Zhang X, Wang F, Shen Y, et al. JAMA Netw Open. 2021;4:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8482055</ArticleId><ArticleId IdType="pubmed">34586367</ArticleId></ArticleIdList></Reference><Reference><Citation>Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: effect of inflammatory biomarkers at three-month follow-up. Mazza MG, Palladini M, De Lorenzo R, et al. Brain Behav Immun. 2021;94:138&#x2013;147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7903920</ArticleId><ArticleId IdType="pubmed">33639239</ArticleId></ArticleIdList></Reference><Reference><Citation>Sex influences immune responses to viruses, and efficacy of prophylaxis and treatments for viral diseases. Klein SL. Bioessays. 2012;34:1050&#x2013;1059.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4120666</ArticleId><ArticleId IdType="pubmed">23012250</ArticleId></ArticleIdList></Reference><Reference><Citation>1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Huang L, Yao Q, Gu X, et al. Lancet. 2021;398:747&#x2013;758.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Post-traumatic stress disorder, depression and anxiety symptoms in COVID-19 outpatients with different levels of respiratory and ventilatory support in the acute phase undergoing three months follow-up. Ferraris M, Maffoni M, DE Marzo V, et al. Minerva Med. 2023;114:169&#x2013;177.</Citation><ArticleIdList><ArticleId IdType="pubmed">35266658</ArticleId></ArticleIdList></Reference><Reference><Citation>Incidence and severity of depression among recovered African Americans with COVID-19-associated respiratory failure. Olanipekun T, Abe T, Effoe V, Westney G, Snyder R. J Racial Ethn Health Disparities. 2022;9:954&#x2013;959.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8023522</ArticleId><ArticleId IdType="pubmed">33825114</ArticleId></ArticleIdList></Reference><Reference><Citation>Remdesivir for the treatment of COVID-19: a systematic review and meta-analysis. Lee TC, Murthy S, Del Corpo O, et al. Clin Microbiol Infect. 2022;28:1203&#x2013;1210.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9117160</ArticleId><ArticleId IdType="pubmed">35598856</ArticleId></ArticleIdList></Reference><Reference><Citation>Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors. Mazza MG, De Lorenzo R, Conte C, et al. Brain Behav Immun. 2020;89:594&#x2013;600.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7390748</ArticleId><ArticleId IdType="pubmed">32738287</ArticleId></ArticleIdList></Reference><Reference><Citation>Influencing factors of anxiety and depression of discharged COVID-19 patients in Wuhan, China. Dai Z, Xiao W, Wang H, et al. PLoS One. 2022;17:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9668158</ArticleId><ArticleId IdType="pubmed">36383607</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>